Arbutus Biopharma Corp Cash Flow Statement

Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -7.32M-12.25M-10.57M-12.79M-14.06M-38.84M-62.72M-384.16M-84.41M-57.06M-153.72M-63.74M-76.25M-69.46M-72.85M-69.92M
Depreciation and Depletion 0.87M1.02M0.99M0.87M0.61M0.53M0.59M1.09M2.03M2.18M2.03M2.00M1.80M1.43M1.40M1.40M
Share-based Compensation 0.23M0.64M0.63M0.77M0.62M2.34M14.22M28.00M15.12M6.24M6.80M6.16M6.42M7.18M9.30M8.99M
Deferred Taxes -16.18M-105.06M-24.32M-4.28M-12.66M
Gains from Investment Securities 1.07M-0.58M3.82M41.98M-9.64M82.55M-35.09M-7.30M-0.17M2.50M1.87M2.23M0.07M2.62M
Asset Writedowns and Impairment 39.01M253.20M40.80M14.81M43.84M
Cash from Restructuring 1.33M-0.98M
Non-cash Items 0.17M1.03M0.45M
Cash from Operations -4.87M-11.10M-7.83M32.91M-6.74M-12.42M-56.38M-57.88M-48.64M-67.87M-71.01M-51.44M-67.53M-35.36M-85.94M-64.85M
Depreciation, Depletion & Amortization
Amortization of Goodwill 138.15M22.50M
Amortizatization of Intangibles 0.28M-0.21M-1.00M0.05M2.20M3.13M
Depreciation & Amortization (CF) 0.87M1.02M0.99M0.87M0.61M0.53M0.59M1.09M2.03M2.18M2.03M2.00M1.80M1.43M1.40M1.40M
Change in Working Capital
Change in Receivables 0.37M2.24M-2.40M0.19M-0.89M1.89M-0.63M-0.73M0.13M1.03M-0.23M0.11M-0.41M0.45M0.42M0.63M
Change in Inventory -0.15M0.15M-0.15M
Change in Accured Expenses 1.04M0.49M-2.14M-0.20M0.13M6.25M-2.49M0.03M0.74M-1.27M-3.31M1.67M1.91M5.22M-5.76M-2.71M
Change in Taxes 0.24M0.12M0.10M0.32M0.03M0.05M0.19M0.05M0.11M0.05M
Investing Activities
Capital Expenditures 1.50M0.82M0.06M0.01M0.72M1.06M2.29M4.00M7.26M1.14M0.59M0.23M0.81M0.51M1.01M0.18M
Sales of Property, Plant and Equipment 0.00M0.08M0.03M0.00M0.03M0.01M0.02M
Acquisitions 0.32M
Change in Acquisitions & Divestments 5.05M118.57M87.67M73.40M70.35M56.00M132.27M164.64M
Cash from Investing Activities 3.55M-0.82M-0.06M-0.01M-0.72M-42.96M7.68M-99.12M27.82M-4.13M28.34M-14.91M-12.68M-74.94M50.77M22.95M
Financing Activities
Other financing activities 0.08M0.05M18.55M
Debt Issuance and Repayment
Long-Term Debt Issuances 12.00M
Long-Term Debt Repayments 12.00M
Net Debt Issuances and Repayments 44.40M65.51M
Change in Capital Stock
Shares Issued 0.01M0.03M4.60M3.84M32.04M56.48M142.18M0.45M0.35M1.38M18.60M86.30M2.11M0.40M0.54M7.48M
Preferred Shares Issued 48.87M66.27M
Dividend Payments
Dividends Paid - Preferred 10.09M11.15M12.12M12.14M
Misc.
Cash from Financing Activities 0.01M0.03M4.61M4.55M32.72M60.68M143.87M12.64M49.32M55.65M37.46M86.75M137.24M31.81M30.65M52.00M
Exchange Rate Effect -0.29M-0.01M-0.10M0.55M-3.56M-1.83M-0.58M1.00M2.37M-1.00M0.07M0.06M0.01M-0.02M0.03M-0.05M
Change in Cash -1.60M-11.89M-3.38M37.99M21.69M3.47M94.59M-143.37M30.88M-17.35M-5.14M20.45M57.03M-78.51M-4.49M10.04M
Free Cash Flow -6.37M-11.92M-7.89M32.89M-7.46M-13.48M-58.67M-61.88M-55.90M-69.00M-71.59M-51.67M-68.34M-35.87M-86.94M-65.03M
Net Cash Flow -1.32M-11.89M-3.28M37.44M25.25M5.30M95.17M-144.37M28.51M-16.35M-5.21M20.40M57.03M-78.48M-4.52M10.09M